sellWeak cluster of 4
John E Sagartz sold $9,479 of NOTV
Chief Strategy Officer at Inotiv, Inc.. 2,118 shares at an average of $4.48, traded Jan 31, 2025, filed Feb 4, 2025.
Warning score
30Value
$9,479
2,118 shares
Holdings after
709,929
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$9k at market
- 0Share of holdings soldSold 0.3% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001062993-25-001621, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 31, 2025 | SOpen-market sale Common Stock | -2,118 | $4.48 | $9,479 | 709,929 | Feb 4, 2025 |
Related signals
Other insiders at Inotiv, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 17Weak | Inotiv, Inc. | Beth A. Taylor Chief Financial Officer | $846 2,888 shares | -2% | |
| 10Weak | Inotiv, Inc. | John E Sagartz Chief Strategy Officer | $616 2,119 shares | -0% | |
| 20Weak | Inotiv, Inc. | Robert Leasure Jr. President and CEO | $4,964 16,810 shares | -1% | |
| 32Weak | NOTVsell Inotiv, Inc. | Robert Leasure Jr. President and CEO | $57k 113,297 shares | -8% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $1,771 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $2,487 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $2,858 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $3,338 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $3,818 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $3,621 2,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.